.png?width=739&name=image%20(46).png "image (46)")
Our focus is breast screening
We combine novel deep learning methods and radiology insights to find malignancies in mammograms. We are the first UK company to receive a CE Mark in deep learning and radiology.
.png "NHSX AI Report Front Cover (1)")
Kheiron is proud to have been profiled in the recent NHSX report, Artificial Intelligence: How to Get it Right. The project that we are working on with EMRAD is mentioned in the ministerial forward as well as further details on pg 57 and 78.
"In the near future, this kind of tech (Mia™) could mean faster diagnosis, more accurate treatments and ultimately more NHS patients hearing the words ‘all clear’."
Matt Hancock, Secretary of State and Baroness Blackwood, Minister for Innovation
.png?width=739&name=image%20(46).png "image%20(46)")
We combine novel deep learning methods and radiology insights to find malignancies in mammograms. We are the first UK company to receive a CE Mark in deep learning and radiology.
Combining radiologists' knowledge with modern machine learning enables an entirely new level of diagnostics we can use to detect cancer and improve patient outcomes.
According to our externally validated clinical trial results, Kheiron’s solution achieves state-of-the-art performance in breast screening support.
Clinical responsibility, rigor, and utility guide everything we do. We work closely with radiologists to build products that help them in real-world everyday practice.
Radiologists are overworked and in short supply. Machine learning can play an important role in solving this problem by improving productivity and easing workloads.
We are working with patients and doctors worldwide to make sure that we deliver on our mission of detecting breast cancer earlier, so patients live longer.
©2019 Kheiron Medical Technologies is a limited company registered in England and Wales.